4.8 Article

A Miniaturized Hemoretractometer for Blood Clot Retraction Testing

Journal

SMALL
Volume 12, Issue 29, Pages 3926-3934

Publisher

WILEY-V C H VERLAG GMBH
DOI: 10.1002/smll.201600274

Keywords

-

Funding

  1. National Science Foundation [ECCS 1231826, CBET 1263889, CMMI 1536087]
  2. National Institutes of Health [R01 HL119542]
  3. UM-SJTU Collaboration on Biomedical Technologies
  4. Michigan Center for Integrative Research in Critical Care (M-CIRCC)
  5. Michigan Translational Research and Commercialization for Life Sciences Program (MTRAC)
  6. National Science Foundation
  7. Directorate For Engineering [1536087] Funding Source: National Science Foundation
  8. Div Of Civil, Mechanical, & Manufact Inn [1536087] Funding Source: National Science Foundation

Ask authors/readers for more resources

Blood coagulation is a critical hemostatic process that must be properly regulated to maintain a delicate balance between bleeding and clotting. Disorders of blood coagulation can expose patients to the risk of either bleeding disorders or thrombotic diseases. Coagulation diagnostics using whole blood is very promising for assessing the complexity of the coagulation system and for global measurements of hemostasis. Despite the clinic values that existing whole blood coagulation tests have demonstrated, these systems have significant limitations that diminish their potential for point-of-care applications. Here, recent advancements in device miniaturization using functional soft materials are leveraged to develop a miniaturized clot retraction force assay device termed mHemoRetractoMeter (mHRM). The mHRM is capable of precise measurements of dynamic clot retraction forces in real time using minute amounts of whole blood. To further demonstrate the clinical utility of the mHRM, systematic studies are conducted using the mHRM to examine the effects of assay temperature, treatments of clotting agents, and pro-and anti-coagulant drugs on clot retraction force developments of whole blood samples. The mHRM's low fabrication cost, small size, and consumption of only minute amounts of blood samples make the technology promising as a point-of-care tool for future coagulation monitoring.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available